Catalyst Wire Dossier Catalyst Wire Dossier

TKM-100201

· Arbutus Biopharma Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TKM-100201, covering 2014-01-09 to 2014-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion [Phase 1]

See pricing